UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Protolabs
PRLB
$2.14B
| $869K | ﹤0.01% |
26,226
+2,328
| +10% | +$72K |
|
2002
Gulfport Energy Corp
GPOR
$2.96B
| $868K | ﹤0.01% |
10,851
-4,846
| -31% | -$351K |
|
|
XRN
2003
Chiron Real Estate Inc
XRN
$475M
| $866K | ﹤0.01% |
19,022
+1,189
| +7% | +$59.8K |
|
2004
iShares MSCI Philippines ETF
EPHE
$147M
| $865K | ﹤0.01% |
32,100
| – | – |
|
|
RNAM
2005
DELISTED
Avidity Biosciences
RNAM
| $864K | ﹤0.01% |
56,306
-3,871
| -6% | -$85.2K |
|
|
TE
2006
T1 Energy
TE
$1.49B
| $864K | ﹤0.01% |
97,134
-1,167
| -1% | -$10.1K |
|
2007
Cimpress
CMPR
$2.3B
| $863K | ﹤0.01% |
19,691
+6,838
| +53% | +$233K |
|
|
THR
2008
DELISTED
Thermon Group Holdings
THR
| $863K | ﹤0.01% |
34,615
+3,909
| +13% | +$95.4K |
|
2009
Heartland Express
HTLD
$914M
| $862K | ﹤0.01% |
54,139
-925
| -2% | -$15K |
|
2010
PureCycle Technologies
PCT
$1.45B
| $861K | ﹤0.01% |
122,965
+19,208
| +19% | +$134K |
|
2011
Tilray
TLRY
$603M
| $855K | ﹤0.01% |
33,796
+4,139
| +14% | +$118K |
|
2012
Ardelyx
ARDX
$972M
| $855K | ﹤0.01% |
+178,469
| New | +$602K |
|
2013
U-Haul Holding Co
UHAL
$14.6B
| $855K | ﹤0.01% |
+14,331
| New | +$902K |
|
2014
Pitney Bowes
PBI
$2.35B
| $853K | ﹤0.01% |
219,277
-1,373
| -0.6% | -$5.77K |
|
2015
Community Health Systems
CYH
$415M
| $851K | ﹤0.01% |
173,609
-67,219
| -28% | -$354K |
|
2016
HCI Group
HCI
$2.35B
| $847K | ﹤0.01% |
+15,807
| New | +$794K |
|
2017
Fortis
FTS
$28.3B
| $847K | ﹤0.01% |
19,910
-5,622
| -22% | -$230K |
|
2018
Unitil
UTL
$965M
| $845K | ﹤0.01% |
14,812
| – | – |
|
2019
Napco Security Technologies
NSSC
$1.44B
| $841K | ﹤0.01% |
+22,367
| New | +$713K |
|
2020
iShares Select Dividend ETF
DVY
$23.6B
| $841K | ﹤0.01% |
+7,173
| New | +$868K |
|
2021
Innoviva
INVA
$1.49B
| $840K | ﹤0.01% |
74,680
+9,690
| +15% | +$118K |
|
|
FORG
2022
DELISTED
ForgeRock, Inc.
FORG
| $837K | ﹤0.01% |
40,612
+3,923
| +11% | +$79.7K |
|
|
PENG
2023
Penguin Solutions Inc
PENG
$2.88B
| $834K | ﹤0.01% |
48,381
+8,343
| +21% | +$139K |
|
2024
Great Southern Bancorp
GSBC
$872M
| $831K | ﹤0.01% |
16,390
+1,087
| +7% | +$61.6K |
|
2025
Anavex Life Sciences
AVXL
$316M
| $831K | ﹤0.01% |
+96,924
| New | +$967K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.